Regulation of neurite growth by inorganic pyrophosphatase 1 via JNK dephosphorylation

PLoS One. 2013 Apr 23;8(4):e61649. doi: 10.1371/journal.pone.0061649. Print 2013.

Abstract

Neural cell differentiation during development is controlled by multiple signaling pathways, in which protein phosphorylation and dephosphorylation play an important role. In this study, we examined the role of pyrophosphatase1 (PPA1) in neuronal differentiation using the loss and gain of function analysis. Neuronal differentiation induced by external factors was studied using a mouse neuroblastoma cell line (N1E115). The neuronal like differentiation in N1E115 cells was determined by morphological analysis based on neurite growth length. In order to analyze the loss of the PPA1 function in N1E115, si-RNA specifically targeting PPA1 was generated. To study the effect of PPA1 overexpression, an adenoviral gene vector containing the PPA1 gene was utilized to infect N1E115 cells. To address the need for pyrophosphatase activity in PPA1, D117A PPA1, which has inactive pyrophosphatase, was overexpressed in N1E115 cells. We used valproic acid (VPA) as a neuronal differentiator to examine the effect of PPA1 in actively differentiated N1E115 cells. Si-PPA1 treatment reduced the PPA1 protein level and led to enhanced neurite growth in N1E115 cells. In contrast, PPA1 overexpression suppressed neurite growth in N1E115 cells treated with VPA, whereas this effect was abolished in D117A PPA1. PPA1 knockdown enhanced the JNK phosphorylation level, and PPA1 overexpression suppressed it in N1E115 cells. It seems that recombinant PPA1 can dephosphorylate JNK while no alteration of JNK phosphorylation level was seen after treatment with recombinant PPA1 D117A. Enhanced neurite growth by PPA1 knockdown was also observed in rat cortical neurons. Thus, PPA1 may play a role in neuronal differentiation via JNK dephosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Amino Acid Substitution
  • Animals
  • Cell Differentiation / drug effects
  • Cell Line, Tumor
  • Cerebral Cortex / cytology
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism*
  • Gene Expression Regulation / drug effects
  • Genetic Vectors
  • Inorganic Pyrophosphatase / antagonists & inhibitors
  • Inorganic Pyrophosphatase / genetics*
  • Inorganic Pyrophosphatase / metabolism
  • MAP Kinase Kinase 4 / genetics*
  • MAP Kinase Kinase 4 / metabolism
  • Mice
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Phosphorylation
  • Primary Cell Culture
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Rats
  • Signal Transduction / drug effects
  • Valproic Acid / pharmacology

Substances

  • RNA, Small Interfering
  • Valproic Acid
  • MAP Kinase Kinase 4
  • Inorganic Pyrophosphatase

Grants and funding

This work was supported in part by research grants from the Scientific Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Astellas Foundation for Research on Metabolic Disorders, the Mitsubishi Pharma Research Foundation, the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and The Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.